NCT00261469View on ClinicalTrials.gov

An Open-label Study to Evaluate Topiramate Therapy in Migraine Patients, and Its Effects on Subject Responsiveness to Migraine Treatment With Triptans

PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

April 30, 2003

Study Completion Date

November 30, 2004

Conditions
Headache
Interventions
DRUG

topiramate

All Listed Sponsors
lead

Janssen-Ortho Inc., Canada

INDUSTRY

NCT00261469 - An Open-label Study to Evaluate Topiramate Therapy in Migraine Patients, and Its Effects on Subject Responsiveness to Migraine Treatment With Triptans | Biotech Hunter | Biotech Hunter